Tandem Diabetes Care (TNDM) Net Margin Growth (3y) (2016 - 2026)
Tandem Diabetes Care (TNDM) Net Margin Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.95 Bn | 176.66 Bn | 6.27 Bn | -388.00 |
| 2 | Stryker | 129.08 Bn | 126.21 Bn | 3.81 Bn | -1.00 |
| 3 | Medtronic | 108.57 Bn | 99.35 Bn | 6.41 Bn | -108.00 |
| 4 | Boston Scientific | 68.52 Bn | 67.07 Bn | 3.61 Bn | 1,692.00 |
| 5 | Edwards Lifesciences | 48.35 Bn | 44.68 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.35 Bn | 27.24 Bn | 750.30 Mn | 1,018.00 |
| 7 | GE HealthCare Technologies | 28.17 Bn | 25.88 Bn | 1.98 Bn | 399.00 |
| 8 | Smith & Nephew | 26.91 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 24.37 Bn | 21.25 Bn | 2.07 Bn | 1,978.00 |
| 10 | Tandem Diabetes Care | 1.14 Bn | 567.17 Mn | 136.79 Mn | 6,490.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6,490.00 |
| Dec 31, 2025 | 702.00 |
| Sep 30, 2025 | 1,544.00 |
| Jun 30, 2025 | -1,427.00 |
| Mar 31, 2025 | -4,733.00 |
| Dec 31, 2024 | -486.00 |
| Sep 30, 2024 | -1,271.00 |
| Jun 30, 2024 | -1,621.00 |
| Mar 31, 2024 | -1,868.00 |
| Dec 31, 2023 | -2,535.00 |
| Sep 30, 2023 | -1,015.00 |
| Jun 30, 2023 | 850.00 |
| Mar 31, 2023 | -5,797.00 |
| Dec 31, 2022 | -965.00 |
| Sep 30, 2022 | -2,087.00 |
| Jun 30, 2022 | -589.00 |
| Mar 31, 2022 | 2,646.00 |
| Dec 31, 2021 | 29.00 |
| Sep 30, 2021 | 7,722.00 |
| Jun 30, 2021 | 5,170.00 |